Path to genome sequencing has changed human microbiome research from focusing on identity characterizations to metagenomics strategies that reveal not only microbial species but also how microbial metabolic activities correlate with human health and disease. The interaction between the human microbiome and the immune system has an effect on several human metabolic activity. Research studies are going on to identify the relation between composition between the microbiome and infectious disease.
MARKET DYNAMICS
The human microbiome sequencing technology market is driving due to the rise in research and development activity in the field of human genome sequencing, advancement in next-generation sequencing (NGS) and other technologies . However, the lack of skilled professional in human microbiome sequencing are expected to hamper the growth of the global human microbiome sequencing technology market.
MARKET SCOPE
The "Human Microbiome Sequencing Technology Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Human Microbiome Sequencing Technology market with detailed market segmentation by type and end user. The Human Microbiome Sequencing Technology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Human Microbiome Sequencing Technology market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Human Microbiome Sequencing Technology market is segmented on the basis of type and application. Based on type, the market is segmented as Traditional Sequencing Technologies,Next-Generation Sequencing,Third Generation Sequencing. On the basis of end user, the market is categorized as Research and Academic Institutions, Pharmaceutical and Biotechnology Companies and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Human Microbiome Sequencing Technology market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Human Microbiome Sequencing Technology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Human Microbiome Sequencing Technology market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Human Microbiome Sequencing Technology market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Human Microbiome Sequencing Technology market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Human Microbiome Sequencing Technology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Human Microbiome Sequencing Technology market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Human Microbiome Sequencing Technology market in these regions.
MARKET PLAYERS
The report covers key developments in the Human Microbiome Sequencing Technology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Human Microbiome Sequencing Technology market are anticipated to have lucrative growth opportunities in the future with the rising demand for Human Microbiome Sequencing Technology in the global market. Below mentioned is the list of few companies engaged in the Human Microbiome Sequencing Technology market.
The report also includes the profiles of key players in Human Microbiome Sequencing Technology market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pacific Biosciences of California, Inc.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Microbiome Insights Inc.
- Leucine Rich Bio Pvt. Ltd.
- Second Genome, Inc.
- Illumina, Inc
- Charles River Laboratories International Inc.
- Oxford Nanopore Technologies, Inc.
- GENEWIZ, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1.INTRODUCTION
1.1.SCOPE OF THE STUDY
1.2.THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.MARKET SEGMENTATION
1.3.1Human Microbiome Sequencing Technology Market - By Type
1.3.2Human Microbiome Sequencing Technology Market - By End User
1.3.3Human Microbiome Sequencing Technology Market - By Region
1.3.3.1By Country
2.KEY TAKEAWAYS
3.RESEARCH METHODOLOGY
4.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET LANDSCAPE
4.1.OVERVIEW
4.2.PEST ANALYSIS
4.2.1North America - Pest Analysis
4.2.2Europe - Pest Analysis
4.2.3Asia-Pacific - Pest Analysis
4.2.4Middle East and Africa - Pest Analysis
4.2.5South and Central America - Pest Analysis
4.3.EXPERT OPINIONS
5.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET - KEY MARKET DYNAMICS
5.1.KEY MARKET DRIVERS
5.2.KEY MARKET RESTRAINTS
5.3.KEY MARKET OPPORTUNITIES
5.4.FUTURE TRENDS
5.5.IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1.HUMAN MICROBIOME SEQUENCING TECHNOLOGY - GLOBAL MARKET OVERVIEW
6.2.HUMAN MICROBIOME SEQUENCING TECHNOLOGY - GLOBAL MARKET AND FORECAST TO 2028
6.3.MARKET POSITIONING/MARKET SHARE
7.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1.OVERVIEW
7.2.TYPE MARKET FORECASTS AND ANALYSIS
7.3.TRADITIONAL SEQUENCING TECHNOLOGIES
7.3.1.Overview
7.3.2.Traditional Sequencing Technologies Market Forecast and Analysis
7.4.NEXT-GENERATION SEQUENCING
7.4.1.Overview
7.4.2.Next-Generation Sequencing Market Forecast and Analysis
7.5.THIRD GENERATION SEQUENCING
7.5.1.Overview
7.5.2.Third Generation Sequencing Market Forecast and Analysis
8.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1.OVERVIEW
8.2.END USER MARKET FORECASTS AND ANALYSIS
8.3.RESEARCH AND ACADEMIC INSTITUTIONS
8.3.1.Overview
8.3.2.Research and Academic Institutions Market Forecast and Analysis
8.4.PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.4.1.Overview
8.4.2.Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
8.5.OTHERS
8.5.1.Overview
8.5.2.Others Market Forecast and Analysis
9.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1.NORTH AMERICA
9.1.1North America Human Microbiome Sequencing Technology Market Overview
9.1.2North America Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.1.3North America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.1.4North America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.1.5North America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.1.5.1United States Human Microbiome Sequencing Technology Market
9.1.5.1.1United States Human Microbiome Sequencing Technology Market by Type
9.1.5.1.2United States Human Microbiome Sequencing Technology Market by End User
9.1.5.2Canada Human Microbiome Sequencing Technology Market
9.1.5.2.1Canada Human Microbiome Sequencing Technology Market by Type
9.1.5.2.2Canada Human Microbiome Sequencing Technology Market by End User
9.1.5.3Mexico Human Microbiome Sequencing Technology Market
9.1.5.3.1Mexico Human Microbiome Sequencing Technology Market by Type
9.1.5.3.2Mexico Human Microbiome Sequencing Technology Market by End User
9.2.EUROPE
9.2.1Europe Human Microbiome Sequencing Technology Market Overview
9.2.2Europe Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.2.3Europe Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.2.4Europe Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.2.5Europe Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.2.5.1Germany Human Microbiome Sequencing Technology Market
9.2.5.1.1Germany Human Microbiome Sequencing Technology Market by Type
9.2.5.1.2Germany Human Microbiome Sequencing Technology Market by End User
9.2.5.2France Human Microbiome Sequencing Technology Market
9.2.5.2.1France Human Microbiome Sequencing Technology Market by Type
9.2.5.2.2France Human Microbiome Sequencing Technology Market by End User
9.2.5.3Italy Human Microbiome Sequencing Technology Market
9.2.5.3.1Italy Human Microbiome Sequencing Technology Market by Type
9.2.5.3.2Italy Human Microbiome Sequencing Technology Market by End User
9.2.5.4Spain Human Microbiome Sequencing Technology Market
9.2.5.4.1Spain Human Microbiome Sequencing Technology Market by Type
9.2.5.4.2Spain Human Microbiome Sequencing Technology Market by End User
9.2.5.5United Kingdom Human Microbiome Sequencing Technology Market
9.2.5.5.1United Kingdom Human Microbiome Sequencing Technology Market by Type
9.2.5.5.2United Kingdom Human Microbiome Sequencing Technology Market by End User
9.3.ASIA-PACIFIC
9.3.1Asia-Pacific Human Microbiome Sequencing Technology Market Overview
9.3.2Asia-Pacific Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.3.3Asia-Pacific Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.3.4Asia-Pacific Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.3.5Asia-Pacific Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.3.5.1Australia Human Microbiome Sequencing Technology Market
9.3.5.1.1Australia Human Microbiome Sequencing Technology Market by Type
9.3.5.1.2Australia Human Microbiome Sequencing Technology Market by End User
9.3.5.2China Human Microbiome Sequencing Technology Market
9.3.5.2.1China Human Microbiome Sequencing Technology Market by Type
9.3.5.2.2China Human Microbiome Sequencing Technology Market by End User
9.3.5.3India Human Microbiome Sequencing Technology Market
9.3.5.3.1India Human Microbiome Sequencing Technology Market by Type
9.3.5.3.2India Human Microbiome Sequencing Technology Market by End User
9.3.5.4Japan Human Microbiome Sequencing Technology Market
9.3.5.4.1Japan Human Microbiome Sequencing Technology Market by Type
9.3.5.4.2Japan Human Microbiome Sequencing Technology Market by End User
9.3.5.5South Korea Human Microbiome Sequencing Technology Market
9.3.5.5.1South Korea Human Microbiome Sequencing Technology Market by Type
9.3.5.5.2South Korea Human Microbiome Sequencing Technology Market by End User
9.4.MIDDLE EAST AND AFRICA
9.4.1Middle East and Africa Human Microbiome Sequencing Technology Market Overview
9.4.2Middle East and Africa Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.4.3Middle East and Africa Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.4.4Middle East and Africa Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.4.5Middle East and Africa Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.4.5.1South Africa Human Microbiome Sequencing Technology Market
9.4.5.1.1South Africa Human Microbiome Sequencing Technology Market by Type
9.4.5.1.2South Africa Human Microbiome Sequencing Technology Market by End User
9.4.5.2Saudi Arabia Human Microbiome Sequencing Technology Market
9.4.5.2.1Saudi Arabia Human Microbiome Sequencing Technology Market by Type
9.4.5.2.2Saudi Arabia Human Microbiome Sequencing Technology Market by End User
9.4.5.3U.A.E Human Microbiome Sequencing Technology Market
9.4.5.3.1U.A.E Human Microbiome Sequencing Technology Market by Type
9.4.5.3.2U.A.E Human Microbiome Sequencing Technology Market by End User
9.5.SOUTH AND CENTRAL AMERICA
9.5.1South and Central America Human Microbiome Sequencing Technology Market Overview
9.5.2South and Central America Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.5.3South and Central America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.5.4South and Central America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.5.5South and Central America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.5.5.1Brazil Human Microbiome Sequencing Technology Market
9.5.5.1.1Brazil Human Microbiome Sequencing Technology Market by Type
9.5.5.1.2Brazil Human Microbiome Sequencing Technology Market by End User
9.5.5.2Argentina Human Microbiome Sequencing Technology Market
9.5.5.2.1Argentina Human Microbiome Sequencing Technology Market by Type
9.5.5.2.2Argentina Human Microbiome Sequencing Technology Market by End User
10.INDUSTRY LANDSCAPE
10.1.MERGERS AND ACQUISITIONS
10.2.AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3.NEW PRODUCT LAUNCHES
10.4.EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET, KEY COMPANY PROFILES
11.1.PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
11.1.1.Key Facts
11.1.2.Business Description
11.1.3.Products and Services
11.1.4.Financial Overview
11.1.5.SWOT Analysis
11.1.6.Key Developments
11.2.THERMO FISHER SCIENTIFIC INC.
11.2.1.Key Facts
11.2.2.Business Description
11.2.3.Products and Services
11.2.4.Financial Overview
11.2.5.SWOT Analysis
11.2.6.Key Developments
11.3.QIAGEN N.V.
11.3.1.Key Facts
11.3.2.Business Description
11.3.3.Products and Services
11.3.4.Financial Overview
11.3.5.SWOT Analysis
11.3.6.Key Developments
11.4.MICROBIOME INSIGHTS INC.
11.4.1.Key Facts
11.4.2.Business Description
11.4.3.Products and Services
11.4.4.Financial Overview
11.4.5.SWOT Analysis
11.4.6.Key Developments
11.5.LEUCINE RICH BIO PVT. LTD.
11.5.1.Key Facts
11.5.2.Business Description
11.5.3.Products and Services
11.5.4.Financial Overview
11.5.5.SWOT Analysis
11.5.6.Key Developments
11.6.SECOND GENOME, INC.
11.6.1.Key Facts
11.6.2.Business Description
11.6.3.Products and Services
11.6.4.Financial Overview
11.6.5.SWOT Analysis
11.6.6.Key Developments
11.7.ILLUMINA, INC
11.7.1.Key Facts
11.7.2.Business Description
11.7.3.Products and Services
11.7.4.Financial Overview
11.7.5.SWOT Analysis
11.7.6.Key Developments
11.8.CHARLES RIVER LABORATORIES INTERNATIONAL INC.
11.8.1.Key Facts
11.8.2.Business Description
11.8.3.Products and Services
11.8.4.Financial Overview
11.8.5.SWOT Analysis
11.8.6.Key Developments
11.9.OXFORD NANOPORE TECHNOLOGIES, INC.
11.9.1.Key Facts
11.9.2.Business Description
11.9.3.Products and Services
11.9.4.Financial Overview
11.9.5.SWOT Analysis
11.9.6.Key Developments
11.10.GENEWIZ, INC.
11.10.1.Key Facts
11.10.2.Business Description
11.10.3.Products and Services
11.10.4.Financial Overview
11.10.5.SWOT Analysis
11.10.6.Key Developments
12.APPENDIX
12.1.ABOUT THE INSIGHT PARTNERS
12.2.GLOSSARY OF TERMS
1. Pacific Biosciences of California, Inc.
2. Thermo Fisher Scientific Inc.
3. QIAGEN N.V.
4. Microbiome Insights Inc.
5. Leucine Rich Bio Pvt. Ltd.
6. Second Genome, Inc.
7. Illumina, Inc
8. Charles River Laboratories International Inc.
9. Oxford Nanopore Technologies, Inc.
10. GENEWIZ, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Human Microbiome Sequencing Technology Market
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Apr 2024